These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3044074)

  • 1. Anti-thymocyte globulin overdosage--risk or potential benefit?
    Zlabinger GJ; Pohanka E; Doleschel W; Zielinski C; Wolf H; Kovarik J
    Am J Med; 1988 Feb; 84(2):369-70. PubMed ID: 3044074
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo and in vitro correlates of high and moderate potency anti-thymocyte globulin in humans.
    Millington GM; Thomas FT; Thomas JM; Mendez-Picon G; Lower RR; Lee HM
    Surg Forum; 1978; 29():369-71. PubMed ID: 401191
    [No Abstract]   [Full Text] [Related]  

  • 3. Antirejection treatment with anti-thymocyte globulin in renal transplant recipients treated with cyclosporine as basic immunosuppression.
    Hoitsma AJ; Wetzels JF; Berden JH; Koene RA
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):12-3. PubMed ID: 3051578
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical uses of anti-thymocyte globulin (ATGAM), Part I.
    Gilbert C
    N C Med J; 1984 Nov; 45(11):737-9. PubMed ID: 6392893
    [No Abstract]   [Full Text] [Related]  

  • 5. Individualized monitoring and modulation of immune reactivity using standardized antithymocyte globulin (ATG).
    Thomas F; Mendez-Picon G; Thomas J; Lee HM
    Transplant Proc; 1979 Jun; 11(2):1429-30. PubMed ID: 382531
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of efficacy and safety between rabbit anti-thymocyte globulin and anti-T lymphocyte globulin in kidney transplantation from donation after cardiac death: a retrospective cohort study.
    Chen GD; Lai XQ; Ko DS; Qiu J; Wang CX; Han M; Li J; Huang G; He XS; Chen LZ
    Nephrology (Carlton); 2015 Aug; 20(8):539-43. PubMed ID: 25808082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential therapy with anti-thymocyte globulin and cyclosporine A in oligoanuric high-risk cadaveric kidney graft recipients.
    Valderrábano F; Anaya F; Robles NR; Jofré R
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):75-8. PubMed ID: 3051597
    [No Abstract]   [Full Text] [Related]  

  • 8. The high dose therapy of anti-human lymphoblast globulin in living related renal transplantation.
    Dohi K; Fukuda Y; Asahara T; Yahata H; Ono E; Takenaka M; Marubayashi S; Omotehara T; Tabe Y; Eto T
    Hiroshima J Med Sci; 1984 Jun; 33(2):223-31. PubMed ID: 6384144
    [No Abstract]   [Full Text] [Related]  

  • 9. Superior renal allograft survival and decreased rejection with early high-dose and sequential multi-species antilymphocyte globulin therapy.
    Thomas F; Cunningham P; Thomas J; Gross U; Gaskins D; Sash C; Parker K
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1874-8. PubMed ID: 3547892
    [No Abstract]   [Full Text] [Related]  

  • 10. Does suppression of T-RFC determine in vivo immunosuppressive effect of ATG?
    Geis WP; Giacchino JL; Buckingham JM; Bansal VK; Iwatsuki S; Kerman RH; Ing TS; Hano JE
    Transplant Proc; 1979 Jun; 11(2):1433-4. PubMed ID: 382533
    [No Abstract]   [Full Text] [Related]  

  • 11. OKT3 treatment of steroid- and/or anti-thymocyte globulin-resistant renal allograft rejection occurring on triple baseline immunosuppression including cyclosporine A.
    Widmer U; Frei D; Keusch G; Burger HR; Largiader F; Binswanger U
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):90-5. PubMed ID: 3140454
    [No Abstract]   [Full Text] [Related]  

  • 12. Tolerance of peripheral veins to antithymocyte globulin after heart transplantation.
    Cantarovich M; Latter DA
    J Heart Lung Transplant; 1994; 13(4):737. PubMed ID: 7947896
    [No Abstract]   [Full Text] [Related]  

  • 13. Low-dose ATGAM treatment sufficiently reduces total T-cell counts and remains clinically effective in prophylactic and anti-rejection protocols.
    Ekberg H; Källén R; Schatz H; Persson NH
    Transplant Proc; 1995 Dec; 27(6):3430-1. PubMed ID: 8540035
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma exchange in steroid and anti-thymocyte globulin resistant allograft rejection in children.
    Nijsten EW; Rees L
    Pediatr Nephrol; 1996 Oct; 10(5):613-5. PubMed ID: 8897567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-day or ten-day ATG treatment for steroid-resistant rejection in kidney transplanted patients.
    Olausson M; Mjörnstedt L; Blohmé I
    Transplant Proc; 1995 Dec; 27(6):3434-5. PubMed ID: 8540037
    [No Abstract]   [Full Text] [Related]  

  • 16. Corticosteroid avoidance in adult kidney transplant recipients under rabbit anti-T-lymphocyte globulin, mycophenolate mofetil and delayed cyclosporine microemulsion introduction.
    Cantarovich D; Rostaing L; Kamar N; Saint-Hillier Y; Ducloux D; Mourad G; Garrigue V; Wolf P; Ellero B; Cassuto E; Albano L; Soulillou JP;
    Transpl Int; 2010 Mar; 23(3):313-24. PubMed ID: 19843296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective randomized comparison of antilymphoblast globulin versus antithymocyte globulin for cadaver kidney transplantation.
    Toledo-Pereyra LH; Bergren C; Mittal VK; Whitten JI; Baskin S; McNichol L
    Transplantation; 1985 Oct; 40(4):448-50. PubMed ID: 3901446
    [No Abstract]   [Full Text] [Related]  

  • 18. Lymphocyte subsets during and after rabbit anti-thymocyte globulin induction in pediatric renal transplantation: sustained T cell depletion.
    Bell L; Girardin C; Sharma A; Goodyer P; Mazer B
    Transplant Proc; 1997 Nov; 29(7A):6S-9S. PubMed ID: 9366917
    [No Abstract]   [Full Text] [Related]  

  • 19. Antilymphocyte globulin (ALG) reverses "irreversible" allograft rejection.
    Light JA; Alijani MR; Biggers JA; Oddenino K; Reinmuth B
    Transplant Proc; 1981 Mar; 13(1 Pt 1):475-81. PubMed ID: 7022877
    [No Abstract]   [Full Text] [Related]  

  • 20. Nursing review of the use and administration of antilymphocyte globulin in renal transplantation.
    Downs SA
    J Am Assoc Nephrol Nurses Tech; 1981 Feb; 8(1):49-51. PubMed ID: 7009705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.